CrowdStrike (CRWD) Stock Forecast & Price Target

Q: What analysts cover CrowdStrike?

CrowdStrike has been rated by research analysts at Argus , Bank of America , Barclays , Benchmark , BMO Capital Markets , BTIG Research , Canaccord Genuity Group , Cantor Fitzgerald , Citigroup , Citizens Jmp , DA Davidson , Evercore , Guggenheim , Jefferies Financial Group , JPMorgan Chase & Co. , KeyCorp , Loop Capital , Mizuho , Morgan Stanley , Needham & Company LLC , Oppenheimer , Piper Sandler , Raymond James Financial , Robert W. Baird , Rosenblatt Securities , Roth Capital , Royal Bank Of Canada , Sanford C. Bernstein , Scotiabank , Stephens , Stifel Nicolaus , TD Cowen , The Goldman Sachs Group , Truist Financial , UBS Group , Wedbush , Weiss Ratings , and Wells Fargo & Company in the past 90 days.

$266.09 +1.34 (+0.51%)

Closing price 04:00 PM Eastern

Extended Trading

$266.30 +0.22 (+0.08%)

As of 07:15 PM Eastern

Compare

CrowdStrike - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 51 Analyst Ratings

Sell
1

Hold
13

Buy
37

Based on 51 Wall Street analysts who have issued ratings for CrowdStrike in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 51 analysts, 1 has given a sell rating, 13 have given a hold rating, and 37 have given a buy rating for CRWD.

Consensus Price Target

$226.53
-14.87% Downside

According to the 51 analysts' twelve-month price targets for CrowdStrike, the average price target is $226.53. The highest price target for CRWD is $425.00, while the lowest price target for CRWD is $112.50. The average price target represents a forecasted downside of -14.87% from the current price of $266.09.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for CRWD and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for CrowdStrike and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRWD Analyst Ratings Over Time

Type	Current Forecast 10/1/25 to 10/1/26	1 Month Ago 9/1/25 to 9/1/26	3 Months Ago 7/3/25 to 7/3/26	1 Year Ago 10/1/24 to 10/1/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	37 Buy rating(s)	37 Buy rating(s)	35 Buy rating(s)	27 Buy rating(s)
Hold	13 Hold rating(s)	13 Hold rating(s)	14 Hold rating(s)	16 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	2 Sell rating(s)	2 Sell rating(s)
Consensus Price Target	$226.53	$218.68	$174.76	$120.95
Forecasted Upside	-14.87% Downside	1.68% Upside	-9.91% Downside	-3.23% Downside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

CRWD Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CRWD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

CrowdStrike Stock vs. The Competition

Type	CrowdStrike	Technology Companies	Broader Market
Consensus Rating Score	2.71	2.23	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	-14.87% Downside	496.35% Upside	21.97% Upside
News Sentiment Rating	Positive News See Recent CRWD News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
9/21/2026	Morgan Stanley 3 of 5 stars	Keith Weiss 2 of 5 stars	Reiterated Rating	Overweight	$238.00 ➝ $254.00	+6.88%
9/18/2026	Bank of America 4 of 5 stars	Tal Liani 4 of 5 stars	Boost Target	Neutral	$230.00 ➝ $260.00	+9.03%
9/18/2026	Stephens 2 of 5 stars	Todd Weller 2 of 5 stars	Boost Target	Overweight	$260.00 ➝ $280.00	+13.96%
9/17/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Weed Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Perform	$119.00 ➝ $132.00	-45.31%
9/11/2026	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Wahrhaftig Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$250.00	+19.70%
9/10/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold (C-) ➝ Hold (C)
9/4/2026	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Colville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Sector Outperform	$250.00 ➝ $265.00	+22.27%
9/4/2026	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Catharine Trebnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$250.00	+16.30%
9/3/2026	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Taz Koujalgi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Buy	$200.00 ➝ $220.00	+2.34%
9/3/2026	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Tindle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Outperform	$240.00 ➝ $250.00	+22.90%
Get the Latest News and Ratings for CRWD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for CrowdStrike and its competitors with MarketBeat's FREE daily newsletter.
9/3/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shaul Eyal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$250.00	+17.49%
9/3/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Hedberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$260.00	+24.37%
9/3/2026	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gray Powell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$245.00	+20.44%
9/3/2026	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$250.00	+22.90%
9/3/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shrenik Kothari Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$230.00 ➝ $235.00	+15.52%
9/2/2026	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rudy Kessinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$245.00	+18.25%
9/1/2026	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Junaid Siddiqui Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Buy	$245.00 ➝ $300.00	+29.87%
8/28/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Bonner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Buy	$230.00 ➝ $425.00	+95.40%
8/28/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Overweight	$230.00 ➝ $235.00	+3.09%
8/27/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$210.00	-4.01%
8/27/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Borg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$240.00	+9.70%
8/27/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gabriela Borges Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$230.00	+21.58%
8/27/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Roger Boyd Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$235.00 ➝ $250.00	+32.15%
8/27/2026	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kingsley Crane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Hold	$185.00 ➝ $210.00	+11.01%
8/27/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Owens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$188.00 ➝ $240.00	+26.86%
8/27/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Fatima Boolani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$250.00 ➝ $260.00	+37.44%
8/27/2026	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Heath Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Overweight	$240.00 ➝ $245.00	+29.51%
8/27/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregg Moskowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Outperform	$240.00 ➝ $250.00	+32.15%
8/27/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Gallo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Buy	$230.00 ➝ $240.00	+26.86%
8/27/2026	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rustam Kanga Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Outperform	$230.00	+2.25%
8/27/2026	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John DiFucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Neutral
8/27/2026	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yi Fu Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$250.00	+32.15%
8/27/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$186.25 ➝ $235.00	+24.22%
8/27/2026	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Ruykhaver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$250.00	+32.15%
8/20/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Essex Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$200.00 ➝ $235.00	+21.69%
8/18/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Saket Kalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Overweight	$169.00 ➝ $235.00	+9.86%
8/14/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
7/27/2026	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yun Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy	$230.00	+27.70%
6/29/2026	Arete Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ellie Kearney Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Buy ➝ Neutral	$182.50	+4.12%
6/24/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Hold	$167.50 ➝ $181.25	+6.76%
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad) Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain. Get the name and ticker of Louis Navellier's #1 AI stock free
6/9/2026	Daiwa Securities Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Outperform	$125.00 ➝ $187.50	+16.20%
6/5/2026	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rahul Chopra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Buy ➝ Hold	$180.00	+0.13%
6/5/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$111.50 ➝ $192.75	+10.94%
6/4/2026	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shyam Patil Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Positive	$118.75 ➝ $200.00	+7.01%
6/4/2026	Capital One Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Overweight	$166.25 ➝ $200.75	+17.82%
6/4/2026	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew DeGasperi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$100.00 ➝ $130.00	-23.40%
5/19/2026	DZ Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Buy ➝ Sell	$125.00	-19.20%
3/30/2026	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Tilton Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Peer Perform ➝ Outperform	$112.50	+21.76%
3/3/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong Sell ➝ Hold
1/27/2026	Macquarie Infrastructure Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Koenig Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Neutral	$121.25	+1.85%
10/15/2025	Westpark Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Casey Ryan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Hold
8/28/2025	New Street Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$115.00	+4.07%
7/10/2025	Cfra Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Janice Quek Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$129.25 ➝ $138.75	+13.91%
11/18/2024	CICC Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Market Perform	$73.75	-13.99%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:05 PM ET.

Should I Buy CrowdStrike Stock? CRWD Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, September 29, 2026. Please send any questions or comments about these CrowdStrike pros and cons to contact@marketbeat.com.

CrowdStrike
Bull Case

Here are some ways that investors could benefit from investing in CrowdStrike Holdings, Inc.:

CrowdStrike Holdings, Inc. is currently trading at $262.74, a level that reflects strong market confidence in its ability to capitalize on the growing demand for AI-driven security solutions, particularly as the company recently announced the availability of its Falcon platform in the OpenAI Marketplace to secure agentic enterprise workflows.
The company demonstrated robust financial momentum in its fiscal second quarter of 2027, reporting revenue of $1.47 billion, which represented a 25.6% year-over-year increase and exceeded analyst consensus estimates, while also generating $377 million in free cash flow, a 33% year-over-year expansion that highlights its strong operational efficiency and cash generation capabilities.
Investors can benefit from the company's successful platform consolidation strategy, evidenced by the addition of approximately $333 million in net new annual recurring revenue (ARR) during the second quarter, a 51% year-over-year expansion that brings total ending ARR to around $5.84 billion, indicating that customers are increasingly adopting multiple modules of the Falcon platform for unified security management.
CrowdStrike Holdings, Inc. is well-positioned to address emerging threats from automated and AI-driven attacks, as its Falcon platform integrates predictive machine learning models to counter real-time malware and zero-day vulnerabilities, a capability that is becoming a non-negotiable operational shield for enterprises facing tighter budget scrutiny in other software categories.
The company's balance sheet remains conservative and liquid, maintaining more than $4 billion in total cash and liquid investments against a debt-to-equity ratio of just 0.15, which provides a strong financial foundation to support its recently authorized $500 million share repurchase program and future strategic initiatives.

CrowdStrike
Bear Case

Investors should be bearish about investing in CrowdStrike Holdings, Inc. for these reasons:

The stock trades at a premium valuation with a trailing price-to-sales multiple near 45x and a forward price-to-earnings ratio around 180x, suggesting that the market has already priced in disciplined execution and sustained revenue expansion, leaving little room for error if growth slows or if the current surge in AI security demand fades.
Wall Street consensus reflects a balanced but cautious outlook, with an average 12-month target price near $222.62, which is slightly below the current trading level of $262.74, indicating that many analysts believe the stock may be overvalued in the near term despite its recent momentum and strong earnings reports.
Management guidance suggests a sequential normalization in net new ARR additions for upcoming quarters, which could trigger brief periods of consolidation and potential stock price volatility as investors adjust their expectations for the pace of revenue growth following the strong performance in the fiscal second quarter of 2027.
There is a risk that the current demand surge is driven by a temporary burst of AI urgency, as management referred to the recent quarter as a "Mythos moment" due to heightened concerns about rogue AI agents, and if this perceived threat level decreases, the company may face slower growth rates as the initial wave of defensive spending subsides.
Insider selling activity has been significant, with CEO George Kurtz and other executives making numerous sales in the past six months, including a recent sale of 10,000 shares at an average price of $261.17, which could signal a lack of confidence in the stock's near-term upside or simply reflect personal financial planning, but it is a factor that some investors may view negatively.

CRWD Forecast - Frequently Asked Questions

According to the research reports of 51 Wall Street equities research analysts, the average twelve-month stock price forecast for CrowdStrike is $226.53, with a high forecast of $425.00 and a low forecast of $112.50.

51 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CrowdStrike in the last year. There is currently 1 sell rating, 13 hold ratings and 37 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CRWD shares.

According to analysts, CrowdStrike's stock has a predicted downside of -14.87% based on their 12-month stock forecasts.

Over the previous 90 days, CrowdStrike's stock had 2 upgrades by analysts.

CrowdStrike has been rated by research analysts at Argus, Bank of America, Barclays, Benchmark, BMO Capital Markets, BTIG Research, Canaccord Genuity Group, Cantor Fitzgerald, Citigroup, Citizens Jmp, DA Davidson, Evercore, Guggenheim, Jefferies Financial Group, JPMorgan Chase & Co., KeyCorp, Loop Capital, Mizuho, Morgan Stanley, Needham & Company LLC, Oppenheimer, Piper Sandler, Raymond James Financial, Robert W. Baird, Rosenblatt Securities, Roth Capital, Royal Bank Of Canada, Sanford C. Bernstein, Scotiabank, Stephens, Stifel Nicolaus, TD Cowen, The Goldman Sachs Group, Truist Financial, UBS Group, Wedbush, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like CrowdStrike more than other "technology" companies. The consensus rating for CrowdStrike is Moderate Buy while the average consensus rating for "technology" companies is Hold. Learn more on how CRWD compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With CrowdStrike Recommendations

MarketBeat monitors more than a dozen sources for CrowdStrike analyst ratings, with the most recent rating issued on 9/21/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CrowdStrike (CRWD) Stock Forecast & Price Target